Press release
Left Ventricular Assist Devices Market 2024-2033: Competitor Assessment, Industry Size And Major Players
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Left Ventricular Assist Devices Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.5 billion in 2023 to $1.64 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to post-market surveillance and data, reduction in device size and noise, awareness and education programs, increased physician experience, adoption in bridge therapy..
The left ventricular assist devices market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expanded indications, rise in heart failure cases, enhanced patient outcomes, market approval and regulatory changes, focus on destination therapy.. Major trends in the forecast period include advancements in implantation techniques, development of dual-pump systems, growing use as a destination therapy, focus on minimizing infection risks, integration with heart failure management programs, improved anticoagulation management..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12042&type=smp
Market Segmentation:
The left ventricular assist devices market covered in this report is segmented -
1) By Type: Transcutaneous Left Ventricular Assist Devices, Implantable Left Ventricular Assist Devices
2) By Type of Flow: Pulsatile, Non-Pulsatile
3) By Application: Bridge-to-Recovery (BTR) Therapy, Bridge-to-Transplant (BTT) Therapy, Destination Therapy, Bridge-to-Candidacy (BTC) Therapy
4) By End-user: Cardiology Centers, Hospitals
Major Driver - Elevated Cardiovascular Disease Rates Propel Left Ventricular Assist Device Market
The rising prevalence of cardiovascular diseases is expected to propel the growth of the left ventricular assist device market going forward. Cardiovascular diseases refer to a group of disorders of the heart and blood vessels. It includes coronary heart disease, congenital heart disease, and others. In the case of advanced heart failure, a left ventricular assist device assists the heart's left ventricle, which pumps blood to the body's tissues. For instance, in October 2022, according to the World Heart Federation (WHF), a Switzerland-based non-governmental organization, the number of cardiovascular diseases (CVD) deaths is projected to rise from an estimated 18,9 million in 2020 to over 22,2 million in 2030. Furthermore, in December 2022, according to data published by New York government, in the United States, heart disease claims the lives of about 697,000 people annually, or 1 in every 5 fatalities where around 805,000 Americans experience a heart attack each year among which 605,000 of these result in a first-time heart attack, while 200,000 are caused by previous heart attacks. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the left ventricular assist device market.
Competitive Landscape:
Major companies operating in the left ventricular assist devices market report are Abbott Laboratories, Medtronic plc., Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., Saft, LivaNova Plc, Thoratec Corporation, Abiomed Inc, Heart Ware International Inc., Transonic Systems, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., AdjuCor GmbH, Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc., Sun Medical Technology Research Corp
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report
Top Trend - Technological Advancements Driving The Left Ventricular Assist Device Market
Technological advancements are a key trend gaining popularity in the left ventricular assist device market. Major companies operating in the left ventricular assist devices market are adopting new technologies to sustain their position in the market. For instance, in January 2021, CorWave SA, a France-based medical device company developing innovative heart pumps, developed left ventricular assist device (LVAD) membrane pump technology. This membrane based LVAD employs a pulse pump (electromagnetic pulses) rather than a rotary pump to flow blood, closely mimicking the action of a heartbeat. It produces a pulsatile pumping activity far more like the natural heart.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Left Ventricular Assist Devices Market Characteristics
3. Left Ventricular Assist Devices Market Trends And Strategies
4. Left Ventricular Assist Devices Market - Macro Economic Scenario
5. Left Ventricular Assist Devices Market Size And Growth
…..
27. Left Ventricular Assist Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
The Business Research Company offers in-depth market insights through Left Ventricular Assist Devices Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.5 billion in 2023 to $1.64 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to post-market surveillance and data, reduction in device size and noise, awareness and education programs, increased physician experience, adoption in bridge therapy..
The left ventricular assist devices market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expanded indications, rise in heart failure cases, enhanced patient outcomes, market approval and regulatory changes, focus on destination therapy.. Major trends in the forecast period include advancements in implantation techniques, development of dual-pump systems, growing use as a destination therapy, focus on minimizing infection risks, integration with heart failure management programs, improved anticoagulation management..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12042&type=smp
Market Segmentation:
The left ventricular assist devices market covered in this report is segmented -
1) By Type: Transcutaneous Left Ventricular Assist Devices, Implantable Left Ventricular Assist Devices
2) By Type of Flow: Pulsatile, Non-Pulsatile
3) By Application: Bridge-to-Recovery (BTR) Therapy, Bridge-to-Transplant (BTT) Therapy, Destination Therapy, Bridge-to-Candidacy (BTC) Therapy
4) By End-user: Cardiology Centers, Hospitals
Major Driver - Elevated Cardiovascular Disease Rates Propel Left Ventricular Assist Device Market
The rising prevalence of cardiovascular diseases is expected to propel the growth of the left ventricular assist device market going forward. Cardiovascular diseases refer to a group of disorders of the heart and blood vessels. It includes coronary heart disease, congenital heart disease, and others. In the case of advanced heart failure, a left ventricular assist device assists the heart's left ventricle, which pumps blood to the body's tissues. For instance, in October 2022, according to the World Heart Federation (WHF), a Switzerland-based non-governmental organization, the number of cardiovascular diseases (CVD) deaths is projected to rise from an estimated 18,9 million in 2020 to over 22,2 million in 2030. Furthermore, in December 2022, according to data published by New York government, in the United States, heart disease claims the lives of about 697,000 people annually, or 1 in every 5 fatalities where around 805,000 Americans experience a heart attack each year among which 605,000 of these result in a first-time heart attack, while 200,000 are caused by previous heart attacks. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the left ventricular assist device market.
Competitive Landscape:
Major companies operating in the left ventricular assist devices market report are Abbott Laboratories, Medtronic plc., Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., Saft, LivaNova Plc, Thoratec Corporation, Abiomed Inc, Heart Ware International Inc., Transonic Systems, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., AdjuCor GmbH, Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc., Sun Medical Technology Research Corp
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report
Top Trend - Technological Advancements Driving The Left Ventricular Assist Device Market
Technological advancements are a key trend gaining popularity in the left ventricular assist device market. Major companies operating in the left ventricular assist devices market are adopting new technologies to sustain their position in the market. For instance, in January 2021, CorWave SA, a France-based medical device company developing innovative heart pumps, developed left ventricular assist device (LVAD) membrane pump technology. This membrane based LVAD employs a pulse pump (electromagnetic pulses) rather than a rotary pump to flow blood, closely mimicking the action of a heartbeat. It produces a pulsatile pumping activity far more like the natural heart.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Left Ventricular Assist Devices Market Characteristics
3. Left Ventricular Assist Devices Market Trends And Strategies
4. Left Ventricular Assist Devices Market - Macro Economic Scenario
5. Left Ventricular Assist Devices Market Size And Growth
…..
27. Left Ventricular Assist Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
